Maria Carlo is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 261 publications with 7,907 citations (h-index 41); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1275 York Ave
New York, NY 10065
Telephone
212-639-2000Registry record last updated 4 Dec 2019.
Clinical trials
- Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
Sponsor: Memorial Sloan Kettering Cancer Center
- Calcium Mass Balance and Dialytic Efficiency of a New cITRate-containing and Acetate-free Dialysis flUidS: CITRUS Study
Sponsor: Azienda Ospedaliera, Ospedale Civile di Legnano
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Exelixis Inc.Program year20241 payment
- Aveo Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
63.3%Kinase inhibitor63.3%Lenvima44%Cabometyx38%Inlyta18%Part D<11 patientsCardiovascular
17.1%Calcium channel blocker17.1%Amlodipine Besylate100%Part D<11 patientsHormonal (systemic)
13.8%l-Thyroxine13.8%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Investigating the Role of KEAP1 Germline and Somatic Mutations in Renal Cell Carcinoma
Sloan-Kettering Inst Can Research
FY2026$266,666K08CA272960 - Investigating the Role of KEAP1 Germline and Somatic Mutations in Renal Cell Carcinoma
Sloan-Kettering Inst Can Research
FY2025$266,666K08CA272960 - Investigating the Role of KEAP1 Germline and Somatic Mutations in Renal Cell Carcinoma
Sloan-Kettering Inst Can Research
FY2024$266,666K08CA272960
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”